Elena Romero-Garcia
L'hospitalet De Llobregat, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Genetic Testing After Heart Transplantation Uncovers Heritable Disease and Drives Family Screening.
Journal: JACC. Advances
Published: April 23, 2026
Heart Transplantation as Salvage Therapy of Candida tropicalis Prosthetic Aortic Valve Endocarditis.
Heart Transplantation as Salvage Therapy of Candida tropicalis Prosthetic Aortic Valve Endocarditis.
Journal: JACC. Case reports
Published: January 06, 2026
Protocol for the ELISPOT-TC Trial: A Randomized Controlled Study Evaluating CMV-Specific Cellular Immune Monitoring in Heart Transplant Recipients.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: September 10, 2025
Porcine Xenotransplantation in End-Stage Kidney Disease.
Journal: The New England journal of medicine
Published: September 03, 2025
PCSK9 Inhibitors in Heart Transplant Recipients.
Journal: Transplantation proceedings
Published: August 21, 2025
A New Prognostic Score Based on Cell-Mediated Immunity for Cytomegalovirus Infection After Transplantation.
Journal: Kidney international reports
Published: April 12, 2025
Spanish heart transplant registry. 36th official report of the Heart Failure Association of the Spanish Society of Cardiology.
Journal: Revista espanola de cardiologia (English ed.)
Published: April 07, 2025
Maintenance Immunosuppression With Tacrolimus and Everolimus in Heart Transplantation Compared With the Usual Tacrolimus and Micophenolate Protocol: Results From a Retrospective Registry.
Journal: Transplantation proceedings
Published: August 08, 2024
Prognostic Role of Tissue Iron Deficiency Measured by sTfR Levels in Heart Failure Patients without Systemic Iron Deficiency or Anemia.
Journal: Journal of clinical medicine
Published: July 04, 2024
Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial.
Journal: The Lancet. Digital health
Published: June 08, 2024
Donor-derived cell-free DNA as a new biomarker for cardiac allograft rejection: A prospective study (FreeDNA-CAR).
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: May 28, 2024
Last Updated: 09/26/2026